Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Maze Therapeutics (NASDAQ:MAZE) through any online brokerage.
Other companies in Maze Therapeutics’s space includes: Atai Beckley NV (NASDAQ:ATAI), WAVE Life Sciences Ltd (NASDAQ:WVE), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Rapport Therapeutics Inc (NASDAQ:RAPP) and Tarsus Pharmaceuticals Inc (NASDAQ:TARS).
Maze Therapeutics has a consensus price target of $41.00.
The stock price for Maze Therapeutics (NASDAQ: MAZE) is $39.71 last updated December 15, 2025 at 4:00 PM EST.
There are no upcoming dividends for Maze Therapeutics.
Maze Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Maze Therapeutics.
Maze Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.